This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Top Analyst Reports for Apple, Philip Morris & Sony
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Bank of Apple Inc. (AAPL), Philip Morris International Inc. (PM) and Sony Group Corp. (SONY), as well as a micro-cap stock Vaso Corp. (VASO).
AAPLNegative Net Change MMMNegative Net Change PMPositive Net Change TRVPositive Net Change VASOPositive Net Change SONYPositive Net Change EXEPositive Net Change
computers consumer-discretionary consumer-staples medical-devices
Should You Buy Boston Scientific Stock Ahead of Q1 Earnings?
by Urmimala Biswas
Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-streak earnings-surprise healthcare medical medical-devices
Newmont Corporation (NEM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NEMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
by Harshit Gupta
Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
CORPositive Net Change PBHPositive Net Change HIMSNegative Net Change
medical medical-devices
Should You Continue to Hold Veracyte Stock in Your Portfolio?
by Zacks Equity Research
Strength in the Afirma and Decipher franchises continues to bode well for VCYT stock.
BSXPositive Net Change MASIPositive Net Change VCYTNegative Net Change HIMSNegative Net Change
medical medical-devices
4 Medical Product Stocks to Buy From a Challenging Industry
by Indrajit Bandyopadhyay
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR are likely to gain from the favorable factors.
PODDNegative Net Change MGNXNegative Net Change CLRBNegative Net Change ALURNegative Net Change
medical medical-devices
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings
by Zacks Equity Research
EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.
EWPositive Net Change MASIPositive Net Change VEEVNegative Net Change HIMSNegative Net Change
earnings medical medical-devices
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm
by Zacks Equity Research
Ceribell secures FDA clearance for Clarity algorithm in pediatric patients, expanding rapid seizure detection capabilities and enhancing critical care efficiency.
ANGONegative Net Change MASIPositive Net Change VEEVNegative Net Change CBLLNegative Net Change
medical medical-devices
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
by Zacks Equity Research
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.
BSXPositive Net Change MASIPositive Net Change STEPositive Net Change HIMSNegative Net Change
medical medical-devices
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth
by Zacks Equity Research
LH's first-quarter 2025 performance is likely to have benefited from both its Dx and BLS businesses.
LHNegative Net Change MASIPositive Net Change VEEVNegative Net Change HIMSNegative Net Change
earnings medical medical-devices
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
by Zacks Equity Research
XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist.
ANGONegative Net Change XRAYNegative Net Change MASIPositive Net Change VEEVNegative Net Change
medical medical-devices
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it
by Debanjana Dey
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.
ABTPositive Net Change TDOCNegative Net Change HIMSNegative Net Change
medical medical-devices
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
by Zacks Equity Research
Lifeward launches ReWalk 7 in the United States, offering advanced mobility, greater control and smarter walking for individuals with spinal cord injuries.
ANGONegative Net Change MASIPositive Net Change VEEVNegative Net Change LFWDNegative Net Change
medical medical-devices
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
by Zacks Equity Research
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
ANGONegative Net Change MASIPositive Net Change VEEVNegative Net Change INGNNegative Net Change
medical medical-devices
CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside?
by Urmimala Biswas
CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now? Let's take a closer look.
UNHNegative Net Change CVSNegative Net Change
healthcare hospitals insurance medical medical-devices
HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold?
by Zacks Equity Research
HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold? Let's break it down.
ANGONegative Net Change MASIPositive Net Change VEEVNegative Net Change HQYNegative Net Change
medical medical-devices
Merit Medical Stock Slips Despite the Launch of New Ventrax System
by Zacks Equity Research
MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.
ANGONegative Net Change MASIPositive Net Change MMSINegative Net Change VEEVNegative Net Change
medical medical-devices
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings
by Zacks Equity Research
DGX's first-quarter 2025 performance is likely to have been supported by the ongoing utilization of its Advanced Diagnostics and benefits from acquisitions.
ABTPositive Net Change DGXPositive Net Change MASIPositive Net Change VEEVNegative Net Change
earnings medical medical-devices
Can ISRG Stock Revive its Growth Momentum After the Sudden Slide?
by Indrajit Bandyopadhyay
Intuitive Surgical has maintained an uptrend since late 2022 with price correcting to 200-DMA a few times and again continuing the uptrend. Will it repeat?
JNJPositive Net Change MDTPositive Net Change ISRGNegative Net Change
medical medical-devices
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
by Urmimala Biswas
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
ABTPositive Net Change NVOPositive Net Change RMDPositive Net Change DXCMNegative Net Change EXASNegative Net Change TNDMNegative Net Change
cancer healthcare hospitals medical medical-devices oncology-screening pharmaceuticals thematic
International Growth Drives GMED Stock Amid Fierce Competition
by Zacks Equity Research
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
ABTPositive Net Change PODDNegative Net Change GMEDNegative Net Change VCYTNegative Net Change
medical medical-devices
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
by Indrajit Bandyopadhyay
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
CAHPositive Net Change CNMDPositive Net Change XRAYNegative Net Change MMSINegative Net Change
medical medical-devices
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care
by Zacks Equity Research
Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room.
ABTPositive Net Change BAXNegative Net Change CORPositive Net Change LMATNegative Net Change
medical medical-devices
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
by Zacks Equity Research
ISRG secures FDA clearance for the first stapler designed for single-port robotic surgery, advancing minimally invasive procedures and enhancing surgical precision.
ANGONegative Net Change ISRGNegative Net Change MASIPositive Net Change VEEVNegative Net Change
medical medical-devices
Bruker Stock May Benefit Following Its Investment in Ridom GmbH
by Zacks Equity Research
BRKR announces a new partnership with NGS bioinformatics solution provider Ridom GmbH.
ABTPositive Net Change PODDNegative Net Change BRKRNegative Net Change VCYTNegative Net Change
medical medical-devices